Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Adaptive Biotechnologies
ADPT
$3.94B
| $1.38M | ﹤0.01% |
229,785
+60,385
| +36% | +$333K |
|
2302
ePlus
PLUS
$2.31B
| $1.37M | ﹤0.01% |
+18,600
| New | +$1.62M |
|
|
DOYU
2303
DouYu International Holdings
DOYU
$142M
| $1.37M | ﹤0.01% |
122,038
-2,100
| -2% | -$22.4K |
|
|
VTYX
2304
DELISTED
Ventyx Biosciences
VTYX
| $1.37M | ﹤0.01% |
624,500
+310,800
| +99% | +$704K |
|
2305
Zedge
ZDGE
$38.4M
| $1.37M | ﹤0.01% |
507,822
-36,592
| -7% | -$106K |
|
|
INFN
2306
DELISTED
Infinera Corporation Common Stock
INFN
| $1.36M | ﹤0.01% |
+207,292
| New | +$1.38M |
|
|
ADAP
2307
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.36M | ﹤0.01% |
2,526,524
+869,949
| +53% | +$634K |
|
2308
KT
KT
$9.11B
| $1.36M | ﹤0.01% |
87,693
-209,959
| -71% | -$3.34M |
|
2309
Vera Bradley
VRA
$93M
| $1.36M | ﹤0.01% |
346,240
-120,700
| -26% | -$602K |
|
2310
LivePerson
LPSN
$35.2M
| $1.36M | ﹤0.01% |
59,678
-56,135
| -48% | -$858K |
|
2311
ThredUp
TDUP
$403M
| $1.36M | ﹤0.01% |
978,745
+420,012
| +75% | +$471K |
|
|
ALE
2312
DELISTED
Allete
ALE
| $1.35M | ﹤0.01% |
20,899
-61,800
| -75% | -$3.99M |
|
|
ESGR
2313
DELISTED
Enstar Group
ESGR
| $1.35M | ﹤0.01% |
4,200
-13,100
| -76% | -$4.24M |
|
|
REFI
2314
Chicago Atlantic Real Estate Finance
REFI
$260M
| $1.35M | ﹤0.01% |
87,686
-10,320
| -11% | -$162K |
|
|
TGI
2315
DELISTED
Triumph Group
TGI
| $1.35M | ﹤0.01% |
72,200
-133,600
| -65% | -$2.22M |
|
2316
SK Telecom
SKM
$14.8B
| $1.34M | ﹤0.01% |
+63,900
| New | +$1.44M |
|
2317
iShares Expanded Tech Sector ETF
IGM
$10.9B
| $1.34M | ﹤0.01% |
13,100
+10,900
| +495% | +$1.1M |
|
2318
AstraZeneca
AZN
$243B
| $1.33M | ﹤0.01% |
10,185
-142,269
| -93% | -$19.9M |
|
2319
Biomea Fusion
BMEA
$95.7M
| $1.33M | ﹤0.01% |
343,732
+261,432
| +318% | +$2.08M |
|
2320
Natural Alternatives International
NAII
$12.8M
| $1.33M | ﹤0.01% |
309,256
-11,600
| -4% | -$51.7K |
|
2321
Mid Penn Bancorp
MPB
$974M
| $1.33M | ﹤0.01% |
46,182
+38,893
| +534% | +$1.2M |
|
|
AFBI
2322
DELISTED
Affinity Bancshares
AFBI
| $1.32M | ﹤0.01% |
75,543
-4,205
| -5% | -$90.3K |
|
2323
Arvinas
ARVN
$587M
| $1.32M | ﹤0.01% |
68,900
-75,500
| -52% | -$1.83M |
|
2324
Quest Resource Holding
QRHC
$33.7M
| $1.32M | ﹤0.01% |
203,192
-22,700
| -10% | -$167K |
|
2325
Investar Holding Corp
ISTR
$426M
| $1.31M | ﹤0.01% |
59,875
-6,800
| -10% | -$149K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.